-
Science & Research
-
Critical Path Initiative
Transforming the way FDA-regulated products are developed, evaluated, and manufactured
What's New
- FDA's Critical Path Announces Sept. 23 Public Hearing on Neglected Tropical Diseases
- TB/Tropical Diseases Grant Opportunity!
For further information go to www.grants.gov - Critical Path Initiative Report on Key Achievements in 2009
- Critical Path Initiative 2010 Update -- Q's and A's
- FDA Approves Chagas Disease Screening Test for Blood, Tissue, and Organ Donors
About Critical Path
The Critical Path Initiative (CPI) is FDA's national strategy for transforming the way FDA-regulated products are developed, evaluated, and manufactured. More
-
Spotlight on Critical Path Projects
Critical Path Project Successes
-
-
Critical Path Reports
Reports on Critical Path Initiative Progress
-
-
Spotlight
-
-
Relevant Information
-
Contact Us
FDA's Office of Critical Path Programs
- 301-796-8490
- FDA Critical Path Program
Dr. Leonard Sacks, Acting Director
-
-
-